CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clotrimazole And Betamethasone Dipropionate, and what generic alternatives are available?
Clotrimazole And Betamethasone Dipropionate is a drug marketed by Actavis Mid Atlantic, Fougera Pharms, Glenmark Speclt, and Taro. and is included in six NDAs.
The generic ingredient in CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE?
- What are the global sales for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE?
- What is Average Wholesale Price for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE?
Summary for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 1 |
What excipients (inactive ingredients) are in CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE? | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE excipients list |
DailyMed Link: | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE at DailyMed |
Recent Clinical Trials for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
See all CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE clinical trials
Pharmacology for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Drug Class | Azole Antifungal Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |